Browsing by Author "Hamad, Anas"
Now showing items 1-9 of 9
-
A Review of Clinical Outcomes Associated with Two Meropenem Dosing Strategies
Wilby, Kyle John; Nasr, Ziad Ghantous; Elazzazy, Shereen; Lau, Tim T. Y.; Hamad, Anas ( Springer International Publishing , 2017 , Article Review)Meropenem is a carbapenem antibiotic that exhibits time-dependent bactericidal activity, traditionally dosed intravenously at 1�g every 8�h. In order to maximize its pharmacodynamic activity and reduce costs, an alternative ... -
Academic Entitlement Among Pharmacy Students in the Arab World: A Multi-National Exploratory Study
Hammoudi Halat, Dalal; Al-Jumaili, Ali Azeez; Ahmed, Kawther Khalid; Rahal, Mohamad; Hamad, Anas; Darwish, Rula M.; Alsous, Mervat M.; Thomas, Dixon; Bukhatwa, Salma; Khdour, Maher; Alkhudair, Nora; Al Balushi, Abdullah Ali; Khalifa, Sherief; Alsharif, Naser Z.... more authors ... less authors (2024 , Article)OBJECTIVE: The study's aim was to explore academic entitlement among pharmacy students in different pharmacy colleges in the Arab World and assess associated factors. METHODS: This study design was a cross-sectional survey. ... -
Applying value-based strategies to accelerate access to novel cancer medications: guidance from the Oncology Health Economics Expert Panel in Qatar (Q-OHEP)
Hamad, Anas; Elazzazy, Shereen; Bujassoum, Salha; Rasul, Kakil; Gaziev, Javid; Cherif, Honar; Al-Boloshi, Zakiya; Hanssens, Yolande; Saleh, Ayman; Rasheed, Hadi Abu; Al-Badriyeh, Daoud; Babiker, Ahmed; Hmaidan, Amid Abu; Al-Hail, Moza... more authors ... less authors ( BioMed Central Ltd , 2023 , Article)Background: In line with global trends, cancer incidence and mortality may have decreased for specific types of cancer in Qatar. However, the cancer-related burden on patients, healthcare systems, and the economy is expected ... -
Cost savings and cost avoidance with the inpatient clinical pharmacist interventions in a tertiary cancer care hospital
Abushanab, Dina; Gulied, Amaal; Hamad, Anas; Abu-Tineh, Mohammad; Abdul Rouf, Palli V.; Al Hail, Moza; El-Kassem, Wessam; El Hajj, Maguy S.; Al-Badriyeh, Daoud... more authors ... less authors ( SAGE , 2023 , Article)Background: The economic benefit of the clinical pharmacist's role in ensuring the optimum use of medicines is potentially considerable, particularly when it comes to cancer management. We sought to evaluate the overall ... -
Cost-Effectiveness and Cost-Utility of Palbociclib versus Ribociclib in Women with Stage IV Breast Cancer: A Real-World Data Evaluation
Al-Ziftawi, Nour Hisham; Alam, Mohammed Fasihul; Elazzazy, Shereen; Shafie, Asrul Akmal; Hamad, Anas; Mohamed Ibrahim, Mohamed Izham... more authors ... less authors ( MDPI , 2022 , Article)Palbociclib and ribociclib are indicated in the first-line treatment of hormonal-receptor-positive HER-2 negative (HR+/HER-2 negative) advanced breast cancer. Despite their clinical benefit, they can increase healthcare ... -
Efficacy and cost effectiveness of intravenous ferric carboxymaltose versus iron sucrose in adult patients with iron deficiency anaemia
Basha, Ahmad; Ibrahim, Mohamed Izham Mohamed; Hamad, Anas; Chandra, Prem; Omar, Nabil E.; Abdullah, Mohamed Abdul Jaber; Aldapt, Mahmood B.; Hussein, Radwa M.; Mahfouz, Ahmed; Adel, Ahmad A.; Shwaylia, Hawraa M.; Ekeibed, Yaslem; AbuMousa, Rami; Yassin, Mohamed A.... more authors ... less authors ( Public Library of Science , 2021 , Article)Background Iron deficiency anaemia (IDA) is a major health issues and common type of nutritional deficiency worldwide. For IDA treatment, intravenous (IV) iron is a useful therapy. Objective To determine the efficacy and ... -
Home Cancer Care Research: A Bibliometric and Visualization Analysis (1990–2021)
Fhoula, Boutheina; Hadid, Majed; Elomri, Adel; Kerbache, Laoucine; Hamad, Anas; Al Thani, Mohammed Hamad J.; Al-Zoubi, Raed M.; Al-Ansari, Abdulla; Aboumarzouk, Omar M.; El Omri, Abdelfatteh... more authors ... less authors ( Multidisciplinary Digital Publishing Institute (MDPI) , 2022 , Article)Home cancer care research (HCCR) has accelerated, as considerable attention has been placed on reducing cancer-related health costs and enhancing cancer patients’ quality of life. Understanding the current status of HCCR ... -
Predictors of community pharmacists’ readiness to manage the effective and safe use of oral anticancer medicines in a developing setting
Dahmani, Sara; Cerbito, Emelith Florendo; Hamad, Anas; Yusuff, Kazeem Babatunde ( SAGE Publications Ltd , 2022 , Article)Background: There is a paucity of studies about the readiness of community pharmacists to manage the safe and effective use of oral anticancer medicines (OAMs) in developing settings. Objectives: Using the readiness component ... -
Quantification of the growth suppression of HER2+ breast cancer colonies under the effect of trastuzumab and PD-1/PD-L1 inhibitor.
Padmanabhan, Regina; Kheraldine, Hadeel; Gupta, Ishita; Meskin, Nader; Hamad, Anas; Vranic, Semir; Al Moustafa, Ala-Eddin... more authors ... less authors ( Frontiers Media , 2022 , Article)Immune checkpoint blockade (ICB)-based therapy is revolutionizing cancer treatment by fostering successful immune surveillance and effector cell responses against various types of cancers. However, patients with HER2+ ...